nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRM5—midbrain—Gilles de la Tourette syndrome	0.0415	0.0583	CbGeAlD
Acamprosate—GRM5—nervous system—Gilles de la Tourette syndrome	0.0341	0.0479	CbGeAlD
Acamprosate—GRM5—central nervous system—Gilles de la Tourette syndrome	0.0328	0.0461	CbGeAlD
Acamprosate—GRM5—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0287	0.0993	CbGpPWpGaD
Acamprosate—GRM5—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0267	0.0925	CbGpPWpGaD
Acamprosate—GRIN1—midbrain—Gilles de la Tourette syndrome	0.0262	0.0368	CbGeAlD
Acamprosate—GRM5—brain—Gilles de la Tourette syndrome	0.0261	0.0366	CbGeAlD
Acamprosate—GRIN2C—nervous system—Gilles de la Tourette syndrome	0.026	0.0365	CbGeAlD
Acamprosate—GRIN2C—central nervous system—Gilles de la Tourette syndrome	0.025	0.0351	CbGeAlD
Acamprosate—GRIN2D—nervous system—Gilles de la Tourette syndrome	0.0241	0.0339	CbGeAlD
Acamprosate—GRIN2D—central nervous system—Gilles de la Tourette syndrome	0.0232	0.0327	CbGeAlD
Acamprosate—GRIN3A—nervous system—Gilles de la Tourette syndrome	0.0227	0.0319	CbGeAlD
Acamprosate—GRIN3A—central nervous system—Gilles de la Tourette syndrome	0.0219	0.0307	CbGeAlD
Acamprosate—GRIN2A—midbrain—Gilles de la Tourette syndrome	0.0218	0.0307	CbGeAlD
Acamprosate—GRIN1—nervous system—Gilles de la Tourette syndrome	0.0215	0.0302	CbGeAlD
Acamprosate—GRIN1—central nervous system—Gilles de la Tourette syndrome	0.0207	0.0291	CbGeAlD
Acamprosate—GRIN2B—nervous system—Gilles de la Tourette syndrome	0.0205	0.0289	CbGeAlD
Acamprosate—GRIN2C—brain—Gilles de la Tourette syndrome	0.0198	0.0279	CbGeAlD
Acamprosate—GRIN2B—central nervous system—Gilles de la Tourette syndrome	0.0198	0.0278	CbGeAlD
Acamprosate—GRIN2D—brain—Gilles de la Tourette syndrome	0.0185	0.0259	CbGeAlD
Acamprosate—GRIN2C—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0183	0.0635	CbGpPWpGaD
Acamprosate—GRIN2A—nervous system—Gilles de la Tourette syndrome	0.0179	0.0252	CbGeAlD
Acamprosate—SLC36A1—nervous system—Gilles de la Tourette syndrome	0.0178	0.0251	CbGeAlD
Acamprosate—GRIN3A—brain—Gilles de la Tourette syndrome	0.0173	0.0244	CbGeAlD
Acamprosate—GRIN2A—central nervous system—Gilles de la Tourette syndrome	0.0173	0.0243	CbGeAlD
Acamprosate—SLC36A1—central nervous system—Gilles de la Tourette syndrome	0.0172	0.0241	CbGeAlD
Acamprosate—GRIN2C—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0171	0.0592	CbGpPWpGaD
Acamprosate—GRIN2D—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.017	0.059	CbGpPWpGaD
Acamprosate—GRIN1—brain—Gilles de la Tourette syndrome	0.0164	0.0231	CbGeAlD
Acamprosate—GRIN2D—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0159	0.055	CbGpPWpGaD
Acamprosate—GRIN2B—brain—Gilles de la Tourette syndrome	0.0157	0.0221	CbGeAlD
Acamprosate—GRIN2A—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.014	0.0485	CbGpPWpGaD
Acamprosate—GABRG2—midbrain—Gilles de la Tourette syndrome	0.0137	0.0193	CbGeAlD
Acamprosate—GRIN2A—brain—Gilles de la Tourette syndrome	0.0137	0.0193	CbGeAlD
Acamprosate—SLC36A1—brain—Gilles de la Tourette syndrome	0.0136	0.0192	CbGeAlD
Acamprosate—GRIN2A—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.013	0.0452	CbGpPWpGaD
Acamprosate—GRIN1—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0122	0.0423	CbGpPWpGaD
Acamprosate—GABRA1—midbrain—Gilles de la Tourette syndrome	0.0121	0.0171	CbGeAlD
Acamprosate—GRIN2B—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.0119	0.0412	CbGpPWpGaD
Acamprosate—GRIN1—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0114	0.0394	CbGpPWpGaD
Acamprosate—GABRG2—nervous system—Gilles de la Tourette syndrome	0.0113	0.0159	CbGeAlD
Acamprosate—GRIN2B—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.0111	0.0384	CbGpPWpGaD
Acamprosate—GABRG2—central nervous system—Gilles de la Tourette syndrome	0.0109	0.0153	CbGeAlD
Acamprosate—GABRB3—midbrain—Gilles de la Tourette syndrome	0.0106	0.0148	CbGeAlD
Acamprosate—GABRA1—nervous system—Gilles de la Tourette syndrome	0.00998	0.014	CbGeAlD
Acamprosate—GABRA1—central nervous system—Gilles de la Tourette syndrome	0.00961	0.0135	CbGeAlD
Acamprosate—GABRB3—nervous system—Gilles de la Tourette syndrome	0.00868	0.0122	CbGeAlD
Acamprosate—GABRG2—brain—Gilles de la Tourette syndrome	0.00864	0.0121	CbGeAlD
Acamprosate—GABRB3—central nervous system—Gilles de la Tourette syndrome	0.00836	0.0117	CbGeAlD
Acamprosate—GABRA1—brain—Gilles de la Tourette syndrome	0.00763	0.0107	CbGeAlD
Acamprosate—GABRB3—brain—Gilles de la Tourette syndrome	0.00663	0.00933	CbGeAlD
Acamprosate—GRM5—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00456	0.0158	CbGpPWpGaD
Acamprosate—GRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00407	0.0141	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00401	0.0139	CbGpPWpGaD
Acamprosate—SLC36A1—SLC-mediated transmembrane transport—SLC6A3—Gilles de la Tourette syndrome	0.00385	0.0133	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00373	0.0129	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00363	0.0126	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00352	0.0122	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00328	0.0114	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00307	0.0106	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00306	0.0106	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00286	0.0099	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00267	0.00926	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.0026	0.00902	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00235	0.00813	CbGpPWpGaD
Acamprosate—GRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0023	0.00796	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00224	0.00777	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00205	0.0071	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00205	0.00709	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.002	0.00691	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00199	0.00689	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.00196	0.00678	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00186	0.00645	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00185	0.00642	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00181	0.00626	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00176	0.00611	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00173	0.006	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00168	0.00583	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—SLC6A3—Gilles de la Tourette syndrome	0.00151	0.00524	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00135	0.00468	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00133	0.00459	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.0013	0.0045	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.00127	0.0044	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00118	0.00408	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.00116	0.00402	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MET—Gilles de la Tourette syndrome	0.00111	0.00386	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.0011	0.00381	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MET—Gilles de la Tourette syndrome	0.00109	0.00376	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00107	0.0037	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000994	0.00344	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000795	0.00275	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—Gilles de la Tourette syndrome	0.000775	0.00268	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000726	0.00252	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000713	0.00247	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000696	0.00241	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000623	0.00216	CbGpPWpGaD
